{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T07:10:08Z","timestamp":1748934608145,"version":"3.41.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s10549-025-07718-2","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T22:48:35Z","timestamp":1748386115000},"page":"237-250","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploring the Nottingham classification: assessing gene expression profiles in breast cancer patients and their association with outcomes"],"prefix":"10.1007","volume":"212","author":[{"given":"Ana Julia Aguiar de","family":"Freitas","sequence":"first","affiliation":[]},{"given":"Rhafaela Lima","family":"Causin","sequence":"additional","affiliation":[]},{"given":"St\u00e9phanie","family":"Calfa","sequence":"additional","affiliation":[]},{"given":"Iara Viana Vidigal","family":"Santana","sequence":"additional","affiliation":[]},{"given":"Mariana","family":"Balie","sequence":"additional","affiliation":[]},{"given":"Welinton","family":"Hirai","sequence":"additional","affiliation":[]},{"given":"Ana Carolina","family":"Laus","sequence":"additional","affiliation":[]},{"given":"Hadson Silva","family":"Araujo","sequence":"additional","affiliation":[]},{"given":"Cassio Murilo","family":"Hidalgo Filho","sequence":"additional","affiliation":[]},{"given":"Fernanda","family":"de Oliveira Bombarda","sequence":"additional","affiliation":[]},{"given":"Vinicius Duval","family":"da Silva","sequence":"additional","affiliation":[]},{"given":"Adriane Feij\u00f3","family":"Evangelista","sequence":"additional","affiliation":[]},{"given":"Cristiano","family":"de P\u00e1dua Souza","sequence":"additional","affiliation":[]},{"given":"Rui Manuel","family":"Reis","sequence":"additional","affiliation":[]},{"given":"M\u00e1rcia Maria Chiquitelli","family":"Marques","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,5,28]]},"reference":[{"issue":"3","key":"7718_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer J Clinicians 71(3):209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA: A Cancer J Clinicians"},{"issue":"1\u20132","key":"7718_CR2","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1159\/000477851","volume":"85","author":"MA Aleskandarany","year":"2018","unstructured":"Aleskandarany MA, Vandenberghe ME, Marchi\u00f2 C, Ellis IO, Sapino A, Rakha EA (2018) Tumour heterogeneity of breast cancer: from morphology to personalised medicine. PAT 85(1\u20132):23\u201334. https:\/\/doi.org\/10.1159\/000477851","journal-title":"PAT"},{"issue":"1","key":"7718_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40164-022-00363-1","volume":"12","author":"L Guo","year":"2023","unstructured":"Guo L, Kong D, Liu J et al (2023) Breast cancer heterogeneity and its implication in personalized precision therapy. Exp Hematol Oncol 12(1):3. https:\/\/doi.org\/10.1186\/s40164-022-00363-1","journal-title":"Exp Hematol Oncol"},{"issue":"1","key":"7718_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1267\/ahc.22-00050","volume":"56","author":"S Masuda","year":"2023","unstructured":"Masuda S, Nakanishi Y (2023) Application of immunohistochemistry in clinical practices as a standardized assay for breast cancer. Acta Histochem Cytochem 56(1):1\u20138. https:\/\/doi.org\/10.1267\/ahc.22-00050","journal-title":"Acta Histochem Cytochem"},{"issue":"8","key":"7718_CR5","doi-asserted-by":"publisher","first-page":"7549","DOI":"10.18632\/aging.103111","volume":"12","author":"J Zhou","year":"2020","unstructured":"Zhou J, Lei J, Wang J, Lian CL, Hua L, Yang LC, Wu SG (2020) Validation of the 8th edition of the American joint committee on cancer pathological prognostic staging for young breast cancer patients. Aging (Albany NY) 12(8):7549\u20137560. https:\/\/doi.org\/10.18632\/aging.103111","journal-title":"Aging (Albany NY)"},{"issue":"5","key":"7718_CR6","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s00428-018-2301-9","volume":"472","author":"G Cserni","year":"2018","unstructured":"Cserni G, Chmielik E, Cserni B, Tot T (2018) The new TNM-based staging of breast cancer. Virchows Arch 472(5):697\u2013703. https:\/\/doi.org\/10.1007\/s00428-018-2301-9","journal-title":"Virchows Arch"},{"issue":"4","key":"7718_CR7","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/bcr2607","volume":"12","author":"EA Rakha","year":"2010","unstructured":"Rakha EA, Reis-Filho JS, Baehner F et al (2010) Breast cancer prognostic classification in the molecular era: the role of histological grade. Breast Cancer Res 12(4):207. https:\/\/doi.org\/10.1186\/bcr2607","journal-title":"Breast Cancer Res"},{"issue":"2","key":"7718_CR8","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1308\/003588414X14055925060514","volume":"97","author":"Y Fong","year":"2015","unstructured":"Fong Y, Evans J, Brook D, Kenkre J, Jarvis P, Gower-Thomas K (2015) The Nottingham prognostic index: five- and ten-year data for all-cause survival within a screened population. Ann R Coll Surg Engl 97(2):137\u2013139. https:\/\/doi.org\/10.1308\/003588414X14055925060514","journal-title":"Ann R Coll Surg Engl"},{"issue":"2","key":"7718_CR9","doi-asserted-by":"publisher","first-page":"e0261035","DOI":"10.1371\/journal.pone.0261035","volume":"17","author":"D Tschodu","year":"2022","unstructured":"Tschodu D, Ulm B, Bendrat K et al (2022) Comparative analysis of molecular signatures reveals a hybrid approach in breast cancer: combining the Nottingham prognostic index with gene expressions into a hybrid signature. PLoS ONE 17(2):e0261035. https:\/\/doi.org\/10.1371\/journal.pone.0261035","journal-title":"PLoS ONE"},{"issue":"6871","key":"7718_CR10","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/415530a","volume":"415","author":"LJ Van\u2019t Veer","year":"2002","unstructured":"Van\u2019t Veer LJ, Dai H, van de Vijver MJ et al (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415(6871):530\u2013536. https:\/\/doi.org\/10.1038\/415530a","journal-title":"Nature"},{"issue":"2","key":"7718_CR11","doi-asserted-by":"publisher","first-page":"248","DOI":"10.3390\/biomedicines10020248","volume":"10","author":"G Munk\u00e1csy","year":"2022","unstructured":"Munk\u00e1csy G, Santarpia L, Gy\u0151rffy B (2022) Gene expression profiling in early breast cancer-patient stratification based on molecular and tumor microenvironment features. Biomedicines 10(2):248. https:\/\/doi.org\/10.3390\/biomedicines10020248","journal-title":"Biomedicines"},{"issue":"24 Pt 1","key":"7718_CR12","doi-asserted-by":"publisher","first-page":"8623","DOI":"10.1158\/1078-0432.CCR-05-0735","volume":"11","author":"MA Cobleigh","year":"2005","unstructured":"Cobleigh MA, Tabesh B, Bitterman P et al (2005) Tumor gene expression and prognosis in breast cancer patients with 10 or more positive lymph nodes. Clin Cancer Res 11(24 Pt 1):8623\u20138631. https:\/\/doi.org\/10.1158\/1078-0432.CCR-05-0735","journal-title":"Clin Cancer Res"},{"issue":"8","key":"7718_CR13","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1056\/NEJMoa1602253","volume":"375","author":"F Cardoso","year":"2016","unstructured":"Cardoso F, Van\u2019t Veer LJ, Bogaerts J et al (2016) 70-Gene signature as an aid to treatment decisions in early-stage breast cancer. N Engl J Med 375(8):717\u2013729. https:\/\/doi.org\/10.1056\/NEJMoa1602253","journal-title":"N Engl J Med"},{"issue":"18","key":"7718_CR14","doi-asserted-by":"publisher","first-page":"6012","DOI":"10.1158\/1078-0432.CCR-11-0926","volume":"17","author":"M Filipits","year":"2011","unstructured":"Filipits M, Rudas M, Jakesz R et al (2011) A new molecular predictor of distant recurrence in ER-positive, HER2-negative breast cancer adds independent information to conventional clinical risk factors. Clin Cancer Res 17(18):6012\u20136020. https:\/\/doi.org\/10.1158\/1078-0432.CCR-11-0926","journal-title":"Clin Cancer Res"},{"issue":"2","key":"7718_CR15","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s10561-021-09941-9","volume":"23","author":"AC Neuber","year":"2022","unstructured":"Neuber AC, Tostes CH, Ribeiro AG et al (2022) The biobank of barretos cancer hospital: 14 years of experience in cancer research. Cell Tissue Bank 23(2):271\u2013284. https:\/\/doi.org\/10.1007\/s10561-021-09941-9","journal-title":"Cell Tissue Bank"},{"issue":"9","key":"7718_CR16","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1038\/s41379-021-00825-7","volume":"34","author":"IA Cree","year":"2021","unstructured":"Cree IA, Tan PH, Travis WD et al (2021) Counting mitoses: si(ze) matters! Mod Pathol 34(9):1651\u20131657. https:\/\/doi.org\/10.1038\/s41379-021-00825-7","journal-title":"Mod Pathol"},{"issue":"2","key":"7718_CR17","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/his.14091","volume":"77","author":"PH Tan","year":"2020","unstructured":"Tan PH, Ellis I, Allison K et al (2020) The 2019 world health organization classification of tumours of the breast. Histopathology 77(2):181\u2013185. https:\/\/doi.org\/10.1111\/his.14091","journal-title":"Histopathology"},{"key":"7718_CR18","unstructured":"nCounter Breast Cancer 360. NanoString. Accessed Dec 28, 2022. https:\/\/nanostring.com\/products\/ncounter-assays-panels\/oncology\/breast-cancer-360\/"},{"issue":"5","key":"7718_CR19","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1111\/his.14863","volume":"82","author":"A Lashen","year":"2023","unstructured":"Lashen A, Toss MS, Fadhil W, Oni G, Madhusudan S, Rakha E (2023) Evaluation oncotype DX\u00ae 21-gene recurrence score and clinicopathological parameters: a single institutional experience. Histopathology 82(5):755\u2013766. https:\/\/doi.org\/10.1111\/his.14863","journal-title":"Histopathology"},{"issue":"7","key":"7718_CR20","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/modpathol.3800114","volume":"17","author":"DV Miller","year":"2004","unstructured":"Miller DV, Leontovich AA, Lingle WL et al (2004) Utilizing Nottingham prognostic index in microarray gene expression profiling of breast carcinomas. Mod Pathol 17(7):756\u2013764. https:\/\/doi.org\/10.1038\/modpathol.3800114","journal-title":"Mod Pathol"},{"issue":"1","key":"7718_CR21","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1186\/s12885-022-09371-0","volume":"22","author":"A F\u00e4ldt Beding","year":"2022","unstructured":"F\u00e4ldt Beding A, Larsson P, Helou K, Einbeigi Z, Parris TZ (2022) Pan-cancer analysis identifies BIRC5 as a prognostic biomarker. BMC Cancer 22(1):322. https:\/\/doi.org\/10.1186\/s12885-022-09371-0","journal-title":"BMC Cancer"},{"issue":"2","key":"7718_CR22","doi-asserted-by":"publisher","first-page":"188407","DOI":"10.1016\/j.bbcan.2020.188407","volume":"1874","author":"R Bayley","year":"2020","unstructured":"Bayley R, Ward C, Garcia P (2020) MYBL2 amplification in breast cancer: molecular mechanisms and therapeutic potential. Biochim Biophys Acta Rev Cancer 1874(2):188407. https:\/\/doi.org\/10.1016\/j.bbcan.2020.188407","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"20","key":"7718_CR23","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1097\/CM9.0000000000001708","volume":"134","author":"ZN Lu","year":"2021","unstructured":"Lu ZN, Song J, Sun TH, Sun G (2021) UBE2C affects breast cancer proliferation through the AKT\/mTOR signaling pathway. Chin Med J (Engl) 134(20):2465\u20132474. https:\/\/doi.org\/10.1097\/CM9.0000000000001708","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"7718_CR24","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12964-018-0266-6","volume":"16","author":"GB Liao","year":"2018","unstructured":"Liao GB, Li XZ, Zeng S et al (2018) Regulation of the master regulator FOXM1 in cancer. Cell Commun Signal 16(1):57. https:\/\/doi.org\/10.1186\/s12964-018-0266-6","journal-title":"Cell Commun Signal"},{"issue":"2","key":"7718_CR25","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s10549-012-2167-5","volume":"135","author":"J Wang","year":"2012","unstructured":"Wang J, Xu B, Yuan P et al (2012) TOP2A amplification in breast cancer is a predictive marker of anthracycline-based neoadjuvant chemotherapy efficacy. Breast Cancer Res Treat 135(2):531\u2013537. https:\/\/doi.org\/10.1007\/s10549-012-2167-5","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"7718_CR26","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1002\/ijc.32900","volume":"147","author":"N Lim","year":"2020","unstructured":"Lim N, Townsend PA (2020) Cdc6 as a novel target in cancer: oncogenic potential, senescence and subcellular localisation. Int J Cancer 147(6):1528\u20131534. https:\/\/doi.org\/10.1002\/ijc.32900","journal-title":"Int J Cancer"},{"issue":"1","key":"7718_CR27","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1186\/s12864-018-4894-4","volume":"19","author":"RF Minchin","year":"2018","unstructured":"Minchin RF, Butcher NJ (2018) Trimodal distribution of arylamine N-acetyltransferase 1 mRNA in breast cancer tumors: association with overall survival and drug resistance. BMC Genomics 19(1):513. https:\/\/doi.org\/10.1186\/s12864-018-4894-4","journal-title":"BMC Genomics"},{"key":"7718_CR28","doi-asserted-by":"publisher","first-page":"639859","DOI":"10.3389\/fonc.2021.639859","volume":"11","author":"CA Edechi","year":"2021","unstructured":"Edechi CA, Ikeogu NM, Akaluka GN et al (2021) The prolactin inducible protein modulates antitumor immune responses and metastasis in a mouse model of triple negative breast cancer. Front Oncol 11:639859. https:\/\/doi.org\/10.3389\/fonc.2021.639859","journal-title":"Front Oncol"},{"issue":"7","key":"7718_CR29","doi-asserted-by":"publisher","first-page":"e23358","DOI":"10.1002\/jbt.23358","volume":"37","author":"D Chang","year":"2023","unstructured":"Chang D, Li L, Xu Z, Chen X (2023) Targeting FOS attenuates malignant phenotypes of breast cancer: evidence from in silico and in vitro studies. J Biochem Mol Toxicol 37(7):e23358. https:\/\/doi.org\/10.1002\/jbt.23358","journal-title":"J Biochem Mol Toxicol"},{"issue":"6","key":"7718_CR30","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.3390\/cancers15061830","volume":"15","author":"MQ Rasmussen","year":"2023","unstructured":"Rasmussen MQ, Tindb\u00e6k G, Nielsen MM et al (2023) Epigenetic silencing of LRP2 Is associated with dedifferentiation and poor survival in multiple solid tumor types. Cancers (Basel) 15(6):1830. https:\/\/doi.org\/10.3390\/cancers15061830","journal-title":"Cancers (Basel)"},{"issue":"1","key":"7718_CR31","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3892\/mmr.2013.1772","volume":"9","author":"G Feng","year":"2014","unstructured":"Feng G, Zhang Y, Yuan H et al (2014) DNA methylation of trefoil factor 1 (TFF1) is associated with the tumorigenesis of gastric carcinoma. Mol Med Rep 9(1):109\u2013117. https:\/\/doi.org\/10.3892\/mmr.2013.1772","journal-title":"Mol Med Rep"},{"issue":"8","key":"7718_CR32","doi-asserted-by":"publisher","first-page":"100594","DOI":"10.1016\/j.mcpro.2023.100594","volume":"22","author":"TS Veth","year":"2023","unstructured":"Veth TS, Francavilla C, Heck AJR, Altelaar M (2023) Elucidating fibroblast growth factor-induced kinome dynamics using targeted mass spectrometry and dynamic modeling. Mol Cell Proteomics 22(8):100594. https:\/\/doi.org\/10.1016\/j.mcpro.2023.100594","journal-title":"Mol Cell Proteomics"},{"issue":"23","key":"7718_CR33","doi-asserted-by":"publisher","first-page":"3634","DOI":"10.1091\/mbc.E13-05-0264","volume":"24","author":"GD Grant","year":"2013","unstructured":"Grant GD, Brooks L, Zhang X et al (2013) Identification of cell cycle\u2013regulated genes periodically expressed in U2OS cells and their regulation by FOXM1 and E2F transcription factors. Mol Biol Cell 24(23):3634\u20133650. https:\/\/doi.org\/10.1091\/mbc.E13-05-0264","journal-title":"Mol Biol Cell"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-025-07718-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-025-07718-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-025-07718-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T06:39:27Z","timestamp":1748932767000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-025-07718-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,28]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["7718"],"URL":"https:\/\/doi.org\/10.1007\/s10549-025-07718-2","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"type":"print","value":"0167-6806"},{"type":"electronic","value":"1573-7217"}],"subject":[],"published":{"date-parts":[[2025,5,28]]},"assertion":[{"value":"18 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relations that could be construed as potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The present study was approved by the Research Ethics Committee of the Barretos Cancer Hospital (approval no. 1212\/2016). Each research participant provided written informed consent for the publication of any data associated with the present study. All information that could be used to identify the study participants was kept confidential and encrypted in a secure database to ensure full confidentiality of clinical information, laboratory findings, and the anonymity of each participant.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The present study was approved by the Research Ethics Committee of the Barretos Cancer Hospital (approval no. 1212\/2016). Each research participant provided written informed consent for the publication of any data associated with the present study. All information that could be used to identify the study participants was kept confidential and encrypted in a secure database to ensure full confidentiality of clinical information, laboratory findings, and the anonymity of each participant.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}